Benjamin F. Edwards & Company, Inc. Corcept Therapeutics Inc Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
403Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$934 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$572 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$458 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$350 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$216 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.05B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...